The incidence of advanced prostate cancer has been increasing in the USA and Japan, although the incidence of all prostate cancer in the USA has decreased since the recommendation of the US preventive service task force for prostate-specific antigen (PSA) screening in 2012 [1]. Here, KLK3 is linked to prostate carcinoma.